Emerging innovative therapeutic approaches leveraging cyclin-dependent kinase inhibitors to treat advanced breast cancer.

Emerging innovative therapeutic approaches leveraging cyclin-dependent kinase inhibitors to treat advanced breast cancer. Clin Pharmacol Ther. 2017 Dec 11;: Authors: Cruz M, Reinert T, Cristofanilli M PMID: 29226311 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/29226311?dopt=Abstract

Source: Clinical Genitourinary Cancer - December 11, 2017 Category: Cancer & Oncology Authors: Cruz M, Reinert T, Cristofanilli M Tags: Clin Pharmacol Ther Source Type: research

More News: Breast Cancer | Cancer | Cancer & Oncology